Exact Mass: 380.1285
Exact Mass Matches: 380.1285
Found 274 metabolites which its exact mass value is equals to given mass value 380.1285
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
3-O-Methylglycyrol
3-O-Methylglycyrol is found in root vegetables. 3-O-Methylglycyrol is isolated from Glycyrrhiza species roots. Isolated from Glycyrrhiza subspecies roots. 3-O-Methylglycyrol is found in root vegetables.
2-(4-Hydroxyphenyl)-3,6-dimethoxy-8,8-dimethyl-4H,8H-benzo[1,2-b:3,4-b']dipyran-4-one
2-(4-Hydroxyphenyl)-3,6-dimethoxy-8,8-dimethyl-4H,8H-benzo[1,2-b:3,4-b]dipyran-4-one is found in citrus. 2-(4-Hydroxyphenyl)-3,6-dimethoxy-8,8-dimethyl-4H,8H-benzo[1,2-b:3,4-b]dipyran-4-one is a constituent of the fruits of tangerine (Citrus reticulata cv. blanco). Constituent of the fruits of tangerine (Citrus reticulata cv. blanco). 2-(4-Hydroxyphenyl)-3,6-dimethoxy-8,8-dimethyl-4H,8H-benzo[1,2-b:3,4-b]dipyran-4-one is found in citrus.
Bmn-673 8R,9S
N-(5-(((5-(1,1-Dimethylethyl)-2-oxazolyl)methyl)thio)-2-thiazolyl)-4-piperidinecarboxamide
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C2185 - Cyclin-Dependent Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent
4-[[2-(2-Acetylsulfanylethyl)-4,6,7-trimethyl-2,3-dihydro-1-benzofuran-5-yl]oxy]-4-oxobutanoic acid
Varespladib
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Varespladib (LY315920) is a potent and selective group IIA, secretory phospholipase A2 (sPLA2) inhibitor with an IC50 of 9 nM. Varespladib exhibits the significant inhibitory effect on sPLA2 activity in serum from various species including rat, rabbit, guinea pig and human with IC50s of 8.1 nM, 5.0 nM, 3.2 nM and 6.2 nM, respectively[1].
Vellokaempferol 3,4-dimethyl ether
Ovalichromene A
3,4-Methylenedioxy-2-methoxy-6,6-dimethlchromeno-[2,3:4,3]-beta-hydroxychalcone
Indicanine A
Robustic acid
Muxiangrin II
Millettocalyxin B
Multijuginol
7-Prenyloxy-8-methoxy-3,4-methylenedioxyisoflavone
4-Hydroxy-3,6-dimethoxy-6,6-dimethylpyrano[2,3:7,8]flavone
3,7,4-trihydroxy-4-(2,4-dihydroxy-6-methylphenyl)flavan
(+)-howiinol A|(+)-howiionol A|(1R,2R)-2-hydroxy-2-((2R,3S)-3-hydroxy-6-oxo-3,6-dihydro-2H-pyran-2-yl)-1-phenylethyl cinnamate|howiinol A
1-(2,2-Dimethyl-5-methoxy-2H-1-benzopyran-6-yl)-3-(1,3-benzodioxol-5-yl)propane-1,3-dione
(5bR,10bR)-5b,10b-dihydro-8-hydroxy-5-methoxy-2,2-dimethyl-2H,11H-benzo[4,5]furo[2,3-d]pyrano[3,2-g]chromene-7-carbaldehyde|gangetial
(2S)-2?,5,7-trihydroxy-6-prenyl-furo[2?,3?:4?,5?]flavanone|cudraflavanone E
4,5,7-trihydroxy-6-(2-hydroxy-3-methylbut-3-enyl)-2-styrylchromone|platachromone C
4,5,7-trihydroxy-8-(2-hydroxy-3-methylbut-3-enyl)-2-styrylchromone|platachromone D
1,2-Di-O-acyl-3-O-(6-O-acyl-beta-D-galactopyranosyl)-sn-glycerol
BIBB 515
BIBB 515 is a potent, selective and orally active 2,3-oxidosqualene cyclase (OSC) inhibitor with ED50 values of 0.2-0.5 mg/kg and 0.36-33.3 mg/kg in rats and mice (1-5 hours), respectively. BIBB 515 exerts lipid-lowering effect mainly by inhibiting the production of low-density lipoprotein (LDL)[1].
Ala Cys Gly Met
Ala Cys Met Gly
Ala Cys Ser Thr
Ala Cys Thr Ser
Ala Gly Cys Met
Ala Gly Met Cys
Ala Met Cys Gly
Ala Met Gly Cys
Ala Ser Cys Thr
Ala Ser Thr Cys
Ala Thr Cys Ser
Ala Thr Ser Cys
Cys Ala Gly Met
Cys Ala Met Gly
Cys Ala Ser Thr
Cys Ala Thr Ser
Cys Cys Gly Val
Cys Cys Val Gly
Cys Gly Ala Met
Cys Gly Cys Val
Cys Gly Met Ala
Cys Gly Thr Thr
Cys Gly Val Cys
Cys Met Ala Gly
Cys Met Gly Ala
Cys Ser Ala Thr
Cys Ser Thr Ala
Cys Thr Ala Ser
Cys Thr Gly Thr
Cys Thr Ser Ala
Cys Thr Thr Gly
Cys Val Cys Gly
Cys Val Gly Cys
Gly Ala Cys Met
Gly Ala Met Cys
Gly Cys Ala Met
Gly Cys Cys Val
Gly Cys Met Ala
Gly Cys Thr Thr
Gly Cys Val Cys
Gly Met Ala Cys
Gly Met Cys Ala
Gly Met Ser Ser
Gly Ser Met Ser
Gly Ser Ser Met
Gly Thr Cys Thr
Gly Thr Thr Cys
Gly Val Cys Cys
Met Ala Cys Gly
Met Ala Gly Cys
Met Cys Ala Gly
Met Cys Gly Ala
Met Gly Ala Cys
Met Gly Cys Ala
Met Gly Ser Ser
Met Ser Gly Ser
Met Ser Ser Gly
Ser Ala Cys Thr
Ser Ala Thr Cys
Ser Cys Ala Thr
Ser Cys Thr Ala
Ser Gly Met Ser
Ser Gly Ser Met
Ser Met Gly Ser
Ser Met Ser Gly
Ser Ser Gly Met
Ser Ser Met Gly
Ser Thr Ala Cys
Ser Thr Cys Ala
Thr Ala Cys Ser
Thr Ala Ser Cys
Thr Cys Ala Ser
Thr Cys Gly Thr
Thr Cys Ser Ala
Thr Cys Thr Gly
Thr Gly Cys Thr
Thr Gly Thr Cys
Thr Ser Ala Cys
Thr Ser Cys Ala
Thr Thr Cys Gly
Thr Thr Gly Cys
Val Cys Cys Gly
Val Cys Gly Cys
Val Gly Cys Cys
4'-Hydroxy-3,6-dimethoxy-6'',6''-dimethylpyrano[2,3:7,8]flavone
Methyl 4-acetoxy-7-(benzyloxy)-6-methoxy-2-naphthoate
(R)-2-(PIPERIDIN-3-YL)ISOINDOLINE-1,3-DIONE (2S,3S)-2,3-DIHYDROXYSUCCINATE
2-aminophthalylhydrazido-n-acetyl-b-d-glucosaminide
[4-(4-chloro-phenyl)-piperazin-1-yl]-naphthalen-2-yl-acetic acid
N-tert-butyl-N-[2-[(5-chloro-1,3-benzoxazol-2-yl)-(3-oxobutyl)amino]ethyl]carbamate
1H-Indole,1-[[[4-ethyl-5-(2-furanyl)-4H-1,2,4-triazol-3-yl]thio]acetyl]-2,3-dimethyl-(9CI)
Biclotymol
C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent
BMN 673
D000970 - Antineoplastic Agents > D000067856 - Poly(ADP-ribose) Polymerase Inhibitors D004791 - Enzyme Inhibitors
Talazoparib
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01X - Other antineoplastic agents > L01XK - Poly (adp-ribose) polymerase (parp) inhibitors C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C62554 - Poly (ADP-Ribose) Polymerase Inhibitor D000970 - Antineoplastic Agents > D000067856 - Poly(ADP-ribose) Polymerase Inhibitors D004791 - Enzyme Inhibitors C471 - Enzyme Inhibitor
Ethanol, 2-[2-(2-phenoxyethoxy)ethoxy]-, 4-methylbenzenesulfonate
4-(3-{[5-(Trifluoromethyl)pyridin-2-Yl]oxy}benzyl)piperidine-1-Carboxylic Acid
Cilastatin Sodium
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors C471 - Enzyme Inhibitor > C783 - Protease Inhibitor
Varespladib
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Varespladib (LY315920) is a potent and selective group IIA, secretory phospholipase A2 (sPLA2) inhibitor with an IC50 of 9 nM. Varespladib exhibits the significant inhibitory effect on sPLA2 activity in serum from various species including rat, rabbit, guinea pig and human with IC50s of 8.1 nM, 5.0 nM, 3.2 nM and 6.2 nM, respectively[1].
N-(3,4-dimethoxyphenyl)-7-methoxy-4,5-dihydrobenzo[g][1,2]benzoxazole-3-carboxamide
N-[1-[(4-fluorophenyl)methyl]-3,5-dimethyl-4-pyrazolyl]-5-(2-furanyl)-3-isoxazolecarboxamide
2-(4-Anilinophenoxy)acetic acid [2-(2-furanylmethylamino)-2-oxoethyl] ester
N-[1-(2-methylpropyl)-3-pyrazolo[3,4-b]quinolinyl]benzenesulfonamide
N-(3-methoxyphenyl)-1,3-dioxo-2-(2-oxolanylmethyl)-5-isoindolecarboxamide
1-[5-(5-chloro-2-methylphenyl)-2-furanyl]-N-[4-(4-morpholinyl)phenyl]methanimine
(3aR,6aS)-3-(3,4-dimethoxyphenyl)-5-(2,4-dimethylphenyl)-3a,6a-dihydropyrrolo[3,4-d]isoxazole-4,6-dione
Ethyl {2-[(4-methylphenyl)amino]-1,3-thiazol-4-yl}(phenylhydrazono)acetate
3-(Benzyloxy)-4-(trimethylsilyl)pyridin-2-yl dimethylsulfamate
methyl 2-[4-ethyl-2-methoxy-5-oxo-2-(9H-pyrido[3,4-b]indol-1-yl)furan-3-yl]acetate
Methyl (9R,12R,21S)-15,20-dioxo-19-oxa-8,16-diazahexacyclo[10.6.4.01,9.02,7.09,21.012,16]docosa-2,4,6,13-tetraene-8-carboxylate
(3S)-5-Bromo-3-(tert-butyldimethylsilyloxy)-1-pivaloyloxypentane
SNS-032 (BMS-387032)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C2185 - Cyclin-Dependent Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent
Tulrampator
Tulrampator (S-47445) is an orally active selective AMPA receptor modulator. Tulrampator possesses procognitive, enhancing synaptic plasticity, anti-depressant-anxiolytic-like, procognitive and potential neuroprotective properties. Tulrampator can be used for research of alzheimer’s disease and in major depressive disorder[1][2][3].